FAM161A

mutation — cross-omics
Cross-omicsMUTATION → RNACell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, FAM161A mutation is significantly associated with the RNA expression of many other genes, with 6 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible FAM161A-associated genes across cancer lineages are PRAMEF18, ITGAD, and FAM205A. Each is linked with FAM161A in more than 1 cancer types. Because this analysis shows association rather than direction, both FAM161A-to-partner and partner-to-FAM161A results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, PRAMEF18 grouped by FAM161A-low versus FAM161A-high in SOFT_TISSUE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (FAM161A→partner) and Y-score (partner→FAM161A) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SOFT_TISSUEPRAMEF18 →+0.026+4.930<.001.00831
LARGE_INTESTINEITGAD →+0.009+2.925.003.00731
LARGE_INTESTINEFAM205A →+0.025+3.614<.001.00631
BLOOD_LeukemiaMYL2 →+0.572+4.152<.001.00931
BLOOD_LeukemiaIFNG →+0.228+4.152<.001.00931
BLOOD_LeukemiaCFHR2 →+0.296+4.539<.001.00731
Each partner links to its Q-omics profile. Showing the 6 strongest of 6 associations by consensus.

PRAMEF18 by FAM161A expression — SOFT_TISSUE

Box plot of PRAMEF18 in FAM161A-low vs FAM161A-high samples in SOFT_TISSUE.

Explore this box plot interactively →

Exploration